164 related articles for article (PubMed ID: 23696113)
1. [Integrated management of patients with chronic inflammatory bowel disease in the Rhine-Main Region: results of the first integrated health-care project IBD in Germany].
Blumenstein I; Tacke W; Filmann N; Zosel C; Bock H; Heuzeroth V; Zeuzem S; Schröder O
Z Gastroenterol; 2013 Jul; 51(7):613-8. PubMed ID: 23696113
[TBL] [Abstract][Full Text] [Related]
2. [Does the hospital cost of care differ for inflammatory bowel disease patients with or without gastrointestinal infections? A case-control study].
Schmidt C; Köhler F; Kräplin T; Hartmann M; Lerch MM; Stallmach A
Z Gastroenterol; 2014 Jul; 52(7):643-8. PubMed ID: 25026005
[TBL] [Abstract][Full Text] [Related]
3. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study.
van der Valk ME; Mangen MJ; Leenders M; Dijkstra G; van Bodegraven AA; Fidder HH; de Jong DJ; Pierik M; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; van de Meeberg PC; van der Meulen-de Jong AE; Ponsioen CY; Bolwerk CJ; Vermeijden JR; Siersema PD; van Oijen MG; Oldenburg B;
Gut; 2014 Jan; 63(1):72-9. PubMed ID: 23135759
[TBL] [Abstract][Full Text] [Related]
4. Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis.
Mak LY; Ng SC; Wong IOL; Li MKK; Lo FH; Wong MTL; Leung CM; Tsang SWC; Chan KH; Sze SF; Shan EHS; Lam BCY; Hui AJ; Hung IFN; Leung WK
J Gastroenterol Hepatol; 2018 Jan; 33(1):141-149. PubMed ID: 28475813
[TBL] [Abstract][Full Text] [Related]
5. Health Care Cost Analysis in a Population-based Inception Cohort of Inflammatory Bowel Disease Patients in the First Year of Diagnosis.
Niewiadomski O; Studd C; Hair C; Wilson J; McNeill J; Knight R; Prewett E; Dabkowski P; Dowling D; Alexander S; Allen B; Tacey M; Connell W; Desmond P; Bell S
J Crohns Colitis; 2015 Nov; 9(11):988-96. PubMed ID: 26129692
[TBL] [Abstract][Full Text] [Related]
6. [Costs and range of health care consumption under general health insurance and sick leaves among patients with inflammatory bowel disease in chosen countries -- a literature review].
Petryszyn P; Ziółkowska J; Paradowski L
Med Pr; 2009; 60(1):59-63. PubMed ID: 19603698
[TBL] [Abstract][Full Text] [Related]
7. Costs of inflammatory bowel disease in Germany.
Stark R; König HH; Leidl R
Pharmacoeconomics; 2006; 24(8):797-814. PubMed ID: 16898849
[TBL] [Abstract][Full Text] [Related]
8. [Cost of early management of chronic inflammatory intestinal disease].
Rolland N; Grandbastien B; Merle V; Gower-Rousseau C; Yzet T; Marti R; Lerebours E; Dupas JL; Czernichow P; Salomez JL; Lebrun T; Cortot A
Gastroenterol Clin Biol; 1999 Apr; 23(4):483-8. PubMed ID: 10416112
[TBL] [Abstract][Full Text] [Related]
9. Cost of Illness in Inflammatory Bowel Disease.
Kamat N; Ganesh Pai C; Surulivel Rajan M; Kamath A
Dig Dis Sci; 2017 Sep; 62(9):2318-2326. PubMed ID: 28766243
[TBL] [Abstract][Full Text] [Related]
10. [Cost evaluation of a model for integrated care of seriously mentally ill patients].
Fischer F; Hoffmann K; Mönter N; Walle M; Beneke R; Negenborn S; Weinmann S; Willich SN; Berghöfer A
Gesundheitswesen; 2014 Feb; 76(2):86-95. PubMed ID: 23737155
[TBL] [Abstract][Full Text] [Related]
11. Direct and Indirect Costs of Inflammatory Bowel Disease: Ten Years of Follow-up in a Danish Population-based Inception Cohort.
Lo B; Vind I; Vester-Andersen MK; Bendtsen F; Burisch J
J Crohns Colitis; 2020 Jan; 14(1):53-63. PubMed ID: 31076743
[TBL] [Abstract][Full Text] [Related]
12. Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry.
Bokemeyer B; Hardt J; Hüppe D; Prenzler A; Conrad S; Düffelmeyer M; Hartmann P; Hoffstadt M; Klugmann T; Schmidt C; Weismüller J; Mittendorf T; Raspe H
J Crohns Colitis; 2013 Jun; 7(5):355-68. PubMed ID: 22503168
[TBL] [Abstract][Full Text] [Related]
13. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
14. The Evolution of Health Care Utilisation and Costs for Inflammatory Bowel Disease Over Ten Years.
Pillai N; Dusheiko M; Maillard MH; Rogler G; Brüngger B; Bähler C; Pittet VEH;
J Crohns Colitis; 2019 May; 13(6):744-754. PubMed ID: 30916775
[TBL] [Abstract][Full Text] [Related]
15. Hospitalisation, surgical and medical recurrence rates in inflammatory bowel disease 2003-2011—a Danish population-based cohort study.
Vester-Andersen MK; Vind I; Prosberg MV; Bengtsson BG; Blixt T; Munkholm P; Andersson M; Jess T; Bendtsen F
J Crohns Colitis; 2014 Dec; 8(12):1675-83. PubMed ID: 25154681
[TBL] [Abstract][Full Text] [Related]
16. Health care and cost of medication for inflammatory bowel disease in the Rhein-Main region, Germany: a multicenter, prospective, internet-based study.
Blumenstein I; Bock H; Weber C; Rambow A; Tacke W; Kihn R; Pfaff R; Orlemann S; Schaeffer R; Schröder O; Dignass A; Hartmann F; Stein J
Inflamm Bowel Dis; 2008 Jan; 14(1):53-60. PubMed ID: 17973301
[TBL] [Abstract][Full Text] [Related]
17. Savings in social expenditures for work incapacity in patients with inflammatory bowel disease depend on access to innovative therapies in Poland.
Zagórowicz E; Binowski G; Strządała D; Pruszko C; Kucha P; Reguła J
Eur J Gastroenterol Hepatol; 2024 Jun; 36(6):695-703. PubMed ID: 38526938
[TBL] [Abstract][Full Text] [Related]
18. The burden of inflammatory bowel disease in Europe.
Burisch J; Jess T; Martinato M; Lakatos PL;
J Crohns Colitis; 2013 May; 7(4):322-37. PubMed ID: 23395397
[TBL] [Abstract][Full Text] [Related]
19. Health costs in anthroposophic therapy users: a two-year prospective cohort study.
Hamre HJ; Witt CM; Glockmann A; Ziegler R; Willich SN; Kiene H
BMC Health Serv Res; 2006 Jun; 6():65. PubMed ID: 16749921
[TBL] [Abstract][Full Text] [Related]
20. [Significant reduction of osteoporosis fracture-related hospitalisation rate due to intensified, multimodal treatment - results from the Integrated Health Care Network Osteoporosis North Rhine].
Niedhart C; Preising A; Eichhorn C
Z Orthop Unfall; 2013 Feb; 151(1):20-4. PubMed ID: 23423587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
